Joban Vaishnav is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. She has special interest in amyloidosis. Dr. Vaishnav earned her medical degree from St. Louis University School of Medicine. She completed a residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Vaishnav is rated as an Elite provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Heart Transplant, and Tissue Biopsy.

Daniel Judge is a Cardiologist in Baltimore, Maryland. Dr. Judge is rated as an Elite provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as a Distinguished provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Primary Localized Cutaneous Amyloidosis, Cardiac Amyloidosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, and Cardiac Ablation.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as a Distinguished provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is rated as a Distinguished provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Advanced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Advanced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Rafael Llinas serves as the Director of Neurology at the Johns Hopkins Bayview Medical Center. His clinical interests include acute stroke treatments, neurovascular imaging and migraine as related to cerebrovascular disease. He also serves as the associate director of the neurology residency program. He was instrumental in establishing the Johns Hopkins Bayview Medical Center Stroke Center. In 2005, in recognition of the Stroke Centers organizational efforts in stroke care, the institution was granted certification as a Primary Stroke Center by the Joint Commission on Accreditation of Healthcare Organizations. Dr. Llinas primary areas of research interests include diffusion-perfusion imaging of stroke, intravenous and intra-arterial thrombolysis for stroke, education of physicians and nurses in stroke identification and stroke care, stroke units and stroke centers. Dr. Rafael Llinas received his medical degree from the New York University School of Medicine. He completed a medical internship at the Boston City Hospital and was a neurology resident in the Harvard-Longwood neurology training program. Following his residency, he was a stroke and cerebrovascular disease fellow for two years at Beth Israel Hospital, Harvard University. Dr. Llinas is rated as an Advanced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Stroke, Cerebral Amyloid Angiopathy, Siderosis, Thrombectomy, and Gastrostomy.

Dr. Victor Urrutia serves as the medical director of the stroke service at The Johns Hopkins Hospital and director of the Sheikh Khalifa Stroke Institute. He focuses on the clinical aspects of cerebrovascular disease (stroke), specifically acute stroke therapy and prevention. Dr. Urrutia currently sees patients at the Stroke Prevention Clinic, located in the Johns Hopkins Outpatient Center in Baltimore on Wednesdays, and cares for patients in The Johns Hopkins Hospital's Brain Rescue Unit. Dr. Victor Urrutia received his medical degree from the University of Panama School of Medicine. He completed his neurology training at MCP Hahnemann University in Philadelphia, now Drexel University College of Medicine. After his residency training, he completed fellowship training in neurocritical care and acute stroke at Drexel University College of Medicine and became a faculty member in the neurocritical care and acute stroke division. He then returned to Panama for two years where he was the first to treat patients with IV thrombolytic therapy for acute stroke. Dr. Urrutia is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Vertigo, Thrombectomy, and Gastrostomy.

Dr. Emmanouil Tampakakis is an Assistant Professor of Medicine at Johns Hopkins University School of Medicine as well as an attending physician at Johns Hopkins Hospital. His research focuses on Stem Cell Biology and Heart Development and Regeneration. Specifically, Dr. Tampakakis lab aims to understanding the biology and regenerative potential of stem cell-derived cardiomyocytes and uses human induced pluripotent stem cells and animal models to model human cardiac disease and deciphering the mechanisms of cardiac maturation. Dr. Tampakakis also holds a cardiology fellowship at Johns Hopkins Hospital. Dr. Tampakakis received his undergraduate degree and M.D. from the University of Crete. He completed an internal medicine residency at Boston University Medical Center. Prior to joining Johns Hopkins in 2012, Dr. Tampakakis was a research fellow in Dr. J. Vita’s laboratory of Vascular Biology at Boston University School of Medicine. At Johns Hopkins, he was a post-doc in the labs of Drs Chulan Kwon and David Kass. Dr. Tampakakis is the recipient of several awards including the AHA outstanding early career investigator award and the ACC Presidential Career Development Award and has received funding from the AHA and the NIH. Videos Meet Our Expert - Emmanouil Tampakakis Recent News Articles and Media Coverage Hopkins researchers discover newborn rats hold secret to manufacturing human heart cells., The Baltimore Sun, (February 11, 2017). Dr. Tampakakis is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, and Heart Failure.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

Neurologist Michelle C. Johansen specializes in prevention and treatment of stroke. She is the inaugural Guy McKhann Associate Professor of Neurology — the title was established in honor of the founder of the Johns Hopkins Department of Neurology. Dr. Johansen’s research and clinical interests focus on stroke etiology and vascular contributions to cognitive decline. She studies the intersection between the brain and the heart, specifically how changes in the heart’s structure and function point toward the cause of stroke and impact brain health, including cognition. She received the American Stroke Association’s Vascular Cognitive Impairment Award for her work showing that myocardial infarction is associated with acute and progressive decline in cognition, the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Johns Hopkins Department of Neurology’s Clinical Faculty Brain Award for excellence in teaching. She has received multiple grants to fund her research from the National Institute of Neurological Disorders and Stroke, the National Institute on Aging and the American Heart Association. Dr. Johansen’s work has been published in many high-ranking medical journals such as The Journal of the American Medical Association, and she has been interviewed as an expert for news outlets such as CNN and Medical News Today, as well as for webinars and podcasts. She is a member of the American Neurological Association and chair of its Education Innovation Committee, and she is a fellow of the American Heart Association. She received her medical degree from the Medical College of Virginia, where she was inducted into the Alpha Omega Alpha Honor Society, and she earned a postdoctoral degree in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Johansen completed a medicine internship and neurology residency at the University of Virginia, followed by a clinical fellowship in cerebrovascular neurology at Johns Hopkins. She joined the Johns Hopkins Department of Neurology faculty in 2017. The Johansen Lab: johansenlab.org Videos Johns Hopkins Medicine A Woman's Journey Executive Women's Briefing 2021 Neurology: Junior Faculty Spotlight. Dr. Johansen is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Stroke, Dementia, Apoplexy, Cerebral Amyloid Angiopathy, and Thrombectomy.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Dr. Barney J. Stern is a neurologist specializing in vascular neurology and neurological complications of sarcoidosis. His work in vascular neurology has covered all aspects of stroke management, including prevention and acute, subacute and chronic care. Dr. Stern also provides complex care management for patients suffering from neurosarcoidosis. His research focuses on understanding the biology and clinical outcomes of neurovascular disease and neurological complications associated with sarcoidosis. Dr. Stern has served as the medical safety monitor on a number of National Institutes of Health (NIH) stroke studies. In his new role at Johns Hopkins, Dr. Stern will be seeing outpatients as a member of the Advanced Clinical Neurology division with Dr. John Probasco. Dr. Stern is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Neurosarcoidosis, Stroke, Herpes Zoster Oticus, Arachnoiditis, and Thrombectomy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy.

Dr. Richard (Rick) Carrick is a general cardiologist in the Johns Hopkins Division of Medicine and is an assistant professor of medicine at the Johns Hopkins School of Medicine. He also serves as associate director of the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. Originally from Massachusetts, he completed his medical training as well as a Ph.D. in Bioengineering at the University of Vermont and did his internal medicine residency training at Tufts Medical Center in Boston, MA. He completed his Cardiovascular Disease Fellowship and a T32 Research Fellowship at Johns Hopkins. His research focuses on the use of advanced computational techniques like machine-learning and artificial intelligence to improve risk stratification in patients with inherited heart disease. Clinically, he specializes in echocardiography and the care of patients with hypertrophic cardiomyopathy (HCM) and other genetic cardiomyopathies. Dr. Carrick is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Ventricular Tachycardia, Arrhythmias, and Cardiac Ablation.

Dr. Saber Tehrani is an Assistant Professor of Neurology at Johns Hopkins University School of Medicine. Dr. Saber Tehrani has unique subspecialty training in vascular neurology, neuro-ophthalmology, and vestibular neurology. He is available for consultation for patients with strokes affecting vision or balance. Research Summary Dr. Saber Tehrani’s research efforts are focused on posterior circulation stroke diagnosis and outcomes, and how such strokes can affect vision and balance. He is using novel ways to objectively measure abnormal eye movements indicative of stroke. Dr. Tehrani is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Vertigo, Stroke, Pica, Gastrostomy, and Stent Placement.

Dr. Robert Weiss is a Clarence Doodeman professor of cardiology as well as a professor of medicine and radiology at the Johns Hopkins University School of Medicine. Dr. Weiss directs a multi-disciplinary team at Johns Hopkins as well as collaborators at Cedars Sinai Medical Center in Los Angeles are dedicated to identifying the most important clinical, genetic, structural, contractile and metabolic causes of sudden cardiac death as well as the means to reverse the underlying pathology and lower risk. His research interests include energetic consequences and causes of heart failure, predictors of sudden cardiac death, non-invasive magnetic resonance, role of creatine kinase in heart failure, spectroscopy and imaging, coronary endothelial function and small animal cardiovascular imaging. Dr. Weiss received an undergraduate degree in physics form Dickinson College and a medical degree from Pennsylvania State University College of Medicine AOA Hershey Medical Center before joining Johns Hopkins in 1983 as an intern and assistant resident. Dr. Weiss has published extensively and has most recently been awarded a fellowship with the International Society of Magnetic Resonance in Medicine. Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Cardiac Amyloidosis. His top areas of expertise are Pulmonary Hypertension, Heart Attack, Pulmonary Veno-Occlusive Disease, and Apoplexy.